Solana Company Q2 2026: Revenue $2.5M, Net Loss $30.3M, PoNS Divested

Solana Co

Revenue $2.5M (vs $43K prior year), staking revenue $2.5M; H1 2026 revenue $6.1M.
Net loss $30.3M ($0.38/share) vs $9.8M loss ($79.73/share) prior year; includes $6.8M severance from PoNS divestiture.
Completed divestiture of legacy PoNS medical device business; built first institutional validator cluster in Tokyo.
Raised $7.9M net in registered direct offering led by Mirae Asset; repurchased $2.3M shares (1.3M shares) in Q2.
G&A expenses $11.1M vs $3.3M prior year; operating loss $32.7M.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.